Tomi Kilgore Tomi Kilgore is MarketWatch’s deputy investing and corporate news editor and is based in…
pharmaceuticals
Novo Nordisk’s Wegovy could soon have a new sales outlet in the U.S.
Telehealth company Hims & Hers says it is in “active discussions” with Novo Nordisk about selling…
Opinion: Biotech is back. Here’s why these rallying stocks belong in your portfolio now.
Published: Nov. 3, 2025 at 9:58 a.m. ET Biotech stocks are emerging from a four-year slump. The…